WASHINGTON, March 10 (Reuters) - Medtronic Inc missed the main effectiveness goal in a study testing an approved brain device for treatment of epilepsy, U.S. device reviewers said in documents ...

Medtronic Percept™ DBS therapy is the only sensing-enabled † DBS system available, allowing a physician to use data from a patient’s brain activity to personalize their treatment. Andy says Medtronic ...

Medical tech company Medtronic has just landed FDA clearance on its Deep Brain Stimulation (DBS) Clinical Programmer and ActivaProgramming application. "This marks a new era of innovation from the ...

MINNEAPOLIS--(BUSINESS WIRE)-- In the largest, randomized, controlled study of deep brain stimulation (DBS) for Parkinson’s disease, Medtronic DBS Therapy was shown to improve motor function for up to ...

The US FDA approves Medtronic’s rechargeable deep brain stimulation for patients with movement disorders and epilepsy. The US Food and Drug Administration (FDA) has approved a rechargeable deep brain ...

The technology is designed to adjust therapy in real time based on a patient’s brain activity, potentially improving symptom control, according to a Feb. 24 news release from the company. The ...

New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever There is no cure for debilitating ...